Home / Stocks / SBC

SBC Medical Group Holdings (SBC, Health Care Services) Stock Valuation & Fair Value Quality business with a solid forward outlook

SBC Medical Group Holdings (SBC, Health Care Services) trades at a blended P/E of 9.9, about 2% below its historical normal valuation, with a forward growth estimate of 3.7% and a PEG of 2.68. Priced at its historical normal P/E of 10.1 on the same blended earnings, the 2026-09-18 close of $4.75 corresponds to about $4.83 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-09-21
Blended P/E
9.9
Normal P/E
10.1
PEG
2.68
Fwd growth
3.7%
Div yield
0.0%
RSI (14)
66.3
Neutral
Technical context
  • Price $4.85 at the 2026-09-23 close, 10.2% above the 20-day average ($4.40) and 30.7% above the 50-day ($3.71).
  • RSI (14) at 66.3.
  • 52-week range $2.87 to $5.14: the price is 5.6% below the high and 69.0% above the low.

The Street vs SeerForecast

Wall Street's mean price target for SBC is $8.75 across 4 analysts, 80.4% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been quality business with a solid forward outlook since 2026-08-07.

Blended P/E and rating by weekBlended P/E moved from 6.3 to 9.9 between 2026-08-07 and 2026-09-21, against a normal P/E of 10.1, with 0 rating changes over 16 recorded weeks.2026-08-07: P/E 6.3, Quality business with a solid forward outlook (recalculated)2026-08-10: P/E 6.5, Quality business with a solid forward outlook2026-08-14: P/E 6.5, Quality business with a solid forward outlook (recalculated)2026-08-17: P/E 7.8, Quality business with a solid forward outlook2026-08-21: P/E 7.8, Quality business with a solid forward outlook (recalculated)2026-08-24: P/E 8.3, Quality business with a solid forward outlook2026-08-27: P/E 8.3, Quality business with a solid forward outlook (recalculated)2026-08-28: P/E 8.3, Quality business with a solid forward outlook (recalculated)2026-08-30: P/E 8.3, Quality business with a solid forward outlook (recalculated)2026-08-31: P/E 8.4, Quality business with a solid forward outlook2026-09-05: P/E 8.4, Quality business with a solid forward outlook (recalculated)2026-09-07: P/E 8.6, Quality business with a solid forward outlook2026-09-12: P/E 8.6, Quality business with a solid forward outlook (recalculated)2026-09-14: P/E 9.3, Quality business with a solid forward outlook2026-09-19: P/E 9.3, Quality business with a solid forward outlook (recalculated)2026-09-21: P/E 9.9, Quality business with a solid forward outlook7.08.09.010.0Aug 7Aug 18Aug 29Sep 10Sep 21Normal P/E 10.1
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-08-07P/E 6.3-37%Quality business with a solid forward outlook
2026-09-21P/E 9.9-2%Quality business with a solid forward outlook ← now

Frequently asked questions

Is SBC Medical Group Holdings stock overvalued?

At a blended P/E of 9.9 versus its historical normal P/E of 10.1, SBC Medical Group Holdings trades about 2% below its typical valuation, with a PEG of 2.68 on 3.7% forward growth. tickerseer currently rates it quality business with a solid forward outlook.

What is SBC Medical Group Holdings's fair value and PEG?

SBC Medical Group Holdings trades at a blended P/E of 9.9 against a historical normal P/E of 10.1, a PEG of 2.68, and a forward growth estimate of 3.7%. Priced at its historical normal P/E of 10.1 on the same blended earnings, the 2026-09-18 close of $4.75 corresponds to about $4.83 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of SBC Medical Group Holdings changed?

tickerseer's rating has been quality business with a solid forward outlook since 2026-08-07.

What is the analyst price target for SBC Medical Group Holdings?

The mean Wall Street price target for SBC Medical Group Holdings is $8.75 across 4 analysts, 80.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track SBC free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.